The Wedding Bells Sound Really Good! iGlarLixi Fixed-Ratio Combination in the Treatment of Type  2 Diabetes: A Narrative Review

This article reviews the results of major randomized controlled trials in people with type 2 diabetes that compared iGlarLixi to other therapeutic regimens, representing different intensification strategies, such as basal supported oral therapy, oral antidiabetic drugs, and a combination of the latter with glucagon-like peptide 1 receptor agonists. Moreover, as a supplement to randomized trials, data from real-world evidence have also been included.PMID:37326901 | DOI:10.1007/s12325-023-02567-1
Source: Adv Data - Category: Epidemiology Authors: Source Type: research